Nuveen Asset Management’s Oric Pharmaceuticals ORIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $1.35M | Hold |
167,502
| – | – | ﹤0.01% | 2560 |
|
|
2024
Q3 | $1.72M | Buy |
167,502
+1,309
| +0.8% | +$13.4K | ﹤0.01% | 2492 |
|
|
2024
Q2 | $1.17M | Buy |
166,193
+30,406
| +22% | +$215K | ﹤0.01% | 2653 |
|
|
2024
Q1 | $1.87M | Hold |
135,787
| – | – | ﹤0.01% | 2437 |
|
|
2023
Q4 | $1.25M | Sell |
135,787
-33,232
| -20% | -$306K | ﹤0.01% | 2627 |
|
|
2023
Q3 | $1.02M | Hold |
169,019
| – | – | ﹤0.01% | 2562 |
|
|
2023
Q2 | $1.31M | Buy |
+169,019
| New | +$1.31M | ﹤0.01% | 2525 |
|
|
2022
Q2 | – | Sell |
-112,748
| Closed | -$753K | – | 3354 |
|
|
2022
Q1 | $753K | Buy |
112,748
+1,589
| +1% | +$10.6K | ﹤0.01% | 2905 |
|
|
2021
Q4 | $1.31M | Sell |
111,159
-8,058
| -7% | -$95.1K | ﹤0.01% | 2754 |
|
|
2021
Q3 | $3.01M | Buy |
119,217
+4,019
| +3% | +$101K | ﹤0.01% | 2483 |
|
|
2021
Q2 | $2.04M | Buy |
115,198
+42,000
| +57% | +$743K | ﹤0.01% | 2704 |
|
|
2021
Q1 | $1.79M | Buy |
73,198
+5,202
| +8% | +$127K | ﹤0.01% | 2667 |
|
|
2020
Q4 | $2.3M | Buy |
67,996
+34,152
| +101% | +$1.16M | ﹤0.01% | 2436 |
|
|
2020
Q3 | $846K | Buy |
33,844
+151
| +0.4% | +$3.78K | ﹤0.01% | 2754 |
|
|
2020
Q2 | $1.14M | Buy |
+33,693
| New | +$1.14M | ﹤0.01% | 2573 |
|